Clinical Application of Methylene Blue for Treatment of Covid-19 Patients
Status:
Recruiting
Trial end date:
2020-09-21
Target enrollment:
Participant gender:
Summary
The severe acute respiratory syndrome caused by COVID-19 is now a global catastrophic event.
Currently there is no approved drug or vaccine for the disease. Methylene blue (MB, oxidized
form, blue color) has been used in many different areas of clinical medicine, ranging from
malaria to orthopedics. Leucomethylene Blue (reduced form of MB, colorless) may be applied
for the treatment of COVID-19 according to the scientific evidences.
Phase:
Phase 1
Details
Lead Sponsor:
Mashhad University of Medical Sciences
Treatments:
Acetylcysteine Ascorbic Acid Methylene Blue N-monoacetylcystine